RGBP — Regen BioPharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Regen BioPharma, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.727	0.051	0.121	0.001	0.07
Net Total Accounts Receivable
Net Total Receivables	0.219	0.254	0	0.095	0.205
Prepaid Expenses
Total Current Assets	0.994	0.336	0.131	0.143	0.275
Long Term Investments
Total Assets	1.21	0.559	0.354	0.161	0.275
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.7	8.6	5.31	5.38	6.56
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.7	8.6	5.46	5.38	6.56
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-13.5	-8.04	-5.1	-5.22	-6.28
Total Liabilities & Shareholders' Equity	1.21	0.559	0.354	0.161	0.275
Total Common Shares Outstanding
Total Preferred Shares Outstanding